Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in 1st line metastatic pancreatic cancer - a multicenter phase II study

Kullmann, F. and Hollerbach, S. and Fuchs, M. and Messmann, H. and Dollinger, M. M. and Trojan, J. and Harder, J. and Gaebele, E. and Hinke, A. and Endlicher, E. (2007) Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in 1st line metastatic pancreatic cancer - a multicenter phase II study. EJC SUPPLEMENTS, 5 (4). p. 269. ISSN 1359-6349

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Petra Gürster
Date Deposited: 01 Dec 2020 11:18
Last Modified: 01 Dec 2020 11:18
URI: https://pred.uni-regensburg.de/id/eprint/32257

Actions (login required)

View Item View Item